key: cord-0849679-5dvnfmjo
authors: Wang, Juan-Juan; Hu, Zhao; Chen, Jian-Ying
title: Characteristics of abnormal serum creatine kinase-MB levels in children with COVID-19
date: 2021-04-19
journal: World J Pediatr
DOI: 10.1007/s12519-020-00402-z
sha: 8182206e1f3da22aa76ba167f714e8c39cb221a9
doc_id: 849679
cord_uid: 5dvnfmjo

nan

having fever or cough. Patients with elevated CK-MB were more likely to have gastrointestinal symptoms (17.5% vs. 5.0%, P = 0.0016). Laboratory test data further confirmed that COVID-19 patients with elevated CK-MB were more likely to have liver damage (47.6% vs. 11.4%, P < 0.001) and pneumonia complications (67.0% vs. 40.7%, P < 0.001) ( Table 1) .

Pediatric patients with elevated CK-MB presented higher numbers of white blood cells (6.932 ± 0.176 vs. 8.182 ± 0.311 × 10 9 /L, P < 0.001) and lymphocytes (2.661 ± 0.082 vs. 4.147 ± 0.203 × 10 9 /L, P < 0.001) and higher serum levels of cytokines [interleukin (IL)-6: 5.106 ± 0.491 vs. 12.810 ± 3.195 pg/mL, P = 0.0034; interferon-γ (IFN-γ): 3.731 ± 0.478 vs. 6.050 ± 1.028 pg/ mL, P = 0.0232]. B lymphocyte counts in children with elevated CK-MB were approximately twofold higher than those in patients with normal serum levels of CK-MB (569 ± 33 vs. 1019 ± 78 × 10 9 /L, P < 0.001). The duration of viral shedding from symptom onset to negative of RT-PCR test on nasopharyngeal swabs was shorter in children with elevated CK-MB (16.540 ± 1.049 vs. 13.850 ± 0.648 days, P = 0.0254) ( Table 1) .

Although the infection rate of SARS-CoV-2 has been lower in children than in adults [6] , an increasing number of pediatric cases have been confirmed worldwide in this ongoing pandemic. Cardiovascular complications are related to adverse clinical outcomes of adult COVID-19 patients, and myocardial damage is strongly associated with the increasing mortality of these patients [7, 8] . However, the features of children with COVID-19 who suffered from myocardial injuries have seldom been reported. Here, we showed that 42.4% of pediatric patients with COVID-19 had abnormally high levels of serum CK-MB, which was consistent with Wang et al.'s report [8] . CK-MB is predominant in the myocardium but not in skeletal muscle and is the secondary substitute for troponins as a marker to diagnose acute myocardial infarction. As such, an increase in serum CK-MB may suggest the possibility of myocardial damage by SARS-CoV-2, and additional investigation of cardiac biomarkers and functions should be performed. Our results also demonstrated that pediatric patients with abnormal levels of serum CK-MB experienced a higher immune response, as they exhibited higher levels of cytokines, such as IL-6 and IFN-γ, and great numbers of immune cells, especially including CD3, CD4 and CD8 T lymphocytes and CD19 B lymphocytes. Hyperinflammatory cytokine storms are considered to play a key role in the disease process of COVID-19 [9] . Aggressive inflammatory responses strongly lead to injury of healthy cells adjacent to the site of infection, which further exacerbates organ damage caused by the elimination of infected cells [10] . This effect might be one potential reason that pediatric COVID-19 patients with elevated serum CK-MB more frequently experienced impairment of multiple organs, including the heart, liver and gastrointestinal tract as shown by elevated function biomarkers or corresponding symptoms. However, lymphocytes, including T cells and B cells, play critical roles in the antiviral immune response, and a higher immune response may also result in a shorter duration of viral shedding, as shown in the patients with elevated levels of serum CK-MB.

In conclusion, elevated serum CK-MB might indicate more organ damages and a higher immune response in children with COVID-19, so additional monitoring should be conducted on these patients with abnormal serum CK-MB levels.

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Single-cell RNAseq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)

Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)

Frequency, causes, predictors, and clinical significance of periprocedural myocardial infarction following percutaneous coronary intervention

Spread of SARS-CoV-2 in the Icelandic population

Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Cytokine storms in cancer and COVID-19

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

We thank the computer center of Wuhan children's Hospital for its support and also thank Wei Li, Xing-Hua Liu, and Yun-Qiao Li from Union Hospital, Tongji Medical College, Huazhong University of Science and Technology for helping complete this project.Author contributions WJJ and HZ contributed equally to this work. WJJ collected the clinical data, conceptualized and designed the project, drafted the manuscript, and analyzed the data. HZ collected the clinical data and analyzed the data. CJY had full access to all of the data in the study and take responsibility for the integrity of the data, and revised the manuscript for important intellectual content. All the authors read and corrected the manuscript and approved the final version.

Ethical approval The study was carried out in accordance with the Declaration of Helsinki and approved by the Ethics Commission of Huazhong University of Science and Technology.

The authors have no conflict of interest to declare.